VTX-804
/ Vivet Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 12, 2022
Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice.
(PubMed, Int J Mol Sci)
- "Importantly, all clinical alterations were notably improved after treatment with VTX-804. This study demonstrates the potential of VTX-804 gene therapy for future clinical translation to CTLN1 patients."
Combination therapy • Journal • Preclinical • CNS Disorders • Gene Therapies • Mood Disorders • Psychiatry • Vascular Neurology • ASS1
1 to 1
Of
1
Go to page
1